The temporal characterization of marrow lipids and adipocytes in a rabbit model of glucocorticoid-induced osteoporosis

Skeletal Radiology

Volumn 42, Issue 9, 2013, Pages 1235-1244

  Li, Guan Wu ^a   Xu, Zheng ^b   Chen, Qi Wen ^c   Chang, Shi Xin ^a   Tian, Ya Nan ^a   Fan, Jing Zheng ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b XinZhuang Community Health Service Center   (China)

^c FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

Author keywords

Adipocyte; Bone mineral density; Glucocorticoid induced osteoporosis; Magnetic resonance spectroscopy; Marrow adiposity

Indexed keywords

METHYLPREDNISOLONE;

ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; BONE DENSITY; BONE MASS; CELL DENSITY; CELL SIZE; CONTROLLED STUDY; CORTICOSTEROID INDUCED OSTEOPOROSIS; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR; HISTOPATHOLOGY; LIPID ANALYSIS; LUMBAR SPINE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SCANNER; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL;

EID: 84881110842     PISSN: 03642348     EISSN: 14322161     Source Type: Journal    
DOI: 10.1007/s00256-013-1659-7     Document Type: Article

References (32)

1. Majumdar SR, Lix LM, Yogendran M, Morin SN, Metge CJ, Leslie WD. Population-based trends in osteoporosis management after new initiations of long-term systemic glucocorticoids (1998-2008). J Clin Endocrinol Metab. 2012;97:1236-42.
2. Bultink IE, Baden M, Lems WF. Glucocorticoid-induced osteoporosis: an update on current pharmacotherapy and future directions. Expert Opin Pharmacother. 2013;14:185-97.
3. Li GW, Tang GY, Liu Y, Tang RB, Peng YF, Li W. MR spectroscopy and micro-CT in evaluation of osteoporosis model in rabbits: comparison with histopathology. Eur Radiol. 2012;22:923-9.
4. Li GW, Chang SX, Xu Z, Chen Y, Bao H, Shi X. Prediction of hip osteoporotic fractures from composite indices of femoral neck strength. Skeletal Radiol. 2013;42:195-201.
5. Van Staa TP, Laan RF, Barton IP, Cohen S, Reid DM, Cooper C. Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy. Arthritis Rheum. 2003;48:3224-9.
6. Kalpakcioglu BB, Engelke K, Genant HK. Advanced imaging assessment of bone fragility in glucocorticoid-induced osteoporosis. Bone. 2011;48:1221-31.
7. Link TM. Osteoporosis imaging: state of the art and advanced imaging. Radiology. 2012;263:3-17.
8. Shen W, Chen J, Gantz M, et al. MRI-measured pelvic bone marrow adipose tissue is inversely related to DXA-measured bone mineral in younger and older adults. Eur J Clin Nutr. 2012;66:983-8.
9. Justesen J, Stenderup K, Ebbesen EN, Mosekilde L, Steiniche T, Kassem M. Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis. Biogerontology. 2001;2:165-71.
10. Li X, Kuo D, Schafer AL, et al. Quantification of vertebral bone marrow fat content using 3 Tesla MR spectroscopy: reproducibility, vertebral variation, and applications in osteoporosis. J Magn Reson Imaging. 2011;33:974-9.
11. Baum T, Yap SP, Karampinos DC, et al. Does vertebral bone marrow fat content correlate with abdominal adipose tissue, lumbar spine bonemineral density, and blood biomarkers in women with type 2 diabetes mellitus? J Magn Reson Imaging. 2012;35:117-24.
12. Castañeda S, Calvo E, Largo R, et al. Characterization of a new experimental model of osteoporosis in rabbits. J Bone Miner Metab. 2008;26:53-9.
13. Luppen CA, Blake CA, Ammirati KM, et al. Recombinant human bone morphogenetic protein-2 enhances osteotomy healing in glucocorticoid-treated rabbits. J Bone Miner Res. 2002;17:301-10.
14. Ebling WF, Szefler SJ, Jusko WJ. Methylprednisolone disposition in rabbits. Analysis, prodrug conversion, reversible metabolism, and comparison with man. Drug Metab Dispos. 1985;13:296-304.
15. Carvas JS, Pereira RM, Caparbo VF, et al. A single dose of zoledronic acid reverses the deleterious effects of glucocorticoids on titanium implant osseointegration. Osteoporos Int. 2010;21:1723-9.
16. Castañeda S, Largo R, Calvo E, et al. Bone mineral measurements of subchondral and trabecular bone in healthy and osteoporotic rabbits. Skeletal Radiol. 2006;35:34-41.
17. Cohen A, Dempster DW, Stein EM, et al. Increased marrow adiposity in premenopausal women with idiopathic osteoporosis. J Clin Endocrinol Metab. 2012;97:2782-91.
18. Teitelbaum SL. Stem cells and osteoporosis therapy. Cell Stem Cell. 2010;7:553-4.
19. Kim KN, Kim BT, Kim KM, et al. The influence of exogenous fat and water on lumbar spine bone mineral density in healthy volunteers. Yonsei Med J. 2012;53:289-93.
20. Blake GM, Griffith JF, Yeung DK, et al. Effect of increasing vertebral marrow fat content on BMD measurement, T-Score status and fracture risk prediction by dual-energy X-ray absorptiometry. Bone. 2009;44:495-501.
21. Yeung DK, Griffith JF, Antonio GE, Lee FK, Woo J, Leung PC. Osteoporosis is associated with increased marrow fat content and decreased marrow fat unsaturation: a proton MR spectroscopy study. J Magn Reson Imaging. 2005;22:279-85.
22. Fazeli PK, Bredella MA, Freedman L, et al. Marrow fat and preadipocyte factor-1 levels decrease with recovery in women with anorexia nervosa. J Bone Miner Res. 2012;27:1864-71.
23. Lin L, Dai SD, Fan GY. Glucocorticoid-induced differentiation of primary cultured bone marrow mesenchymal cells into adipocytes is antagonized by exogenous Runx2. APMIS. 2010;118:595-605.
24. Rosen CJ, Ackert-Bicknell C, Rodriguez JP, Pino AM. Marrow fat and the bone microenvironment: developmental, functional, and pathological implications. Crit Rev Eukaryot Gene Expr. 2009;19:109-24.
25. Naveiras O, Nardi V, Wenzel PL, et al. Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment. Nature. 2009;460:259-63.
26. Rosen CJ, Bouxsein ML. Mechanisms of disease: is osteoporosis the obesity of bone? Nat Clin Pract Rheumatol. 2006;2:35-43.
27. Wehrli FW, Hopkins JA, Hwang SN, Song HK, Snyder PJ, Haddad JG. Cross-sectional study of osteopenia with quantitative MR imaging and bone densitometry. Radiology. 2000;2172:527-38.
28. Veilleux A, Laberge PY, Morency J, Noël S, Luu-The V, Tchernof A. Expression of genes related to glucocorticoid action in human subcutaneous and omental adipose tissue. J Steroid Biochem Mol Biol. 2010;122:28-34.
29. Veilleux A, Rhéaume C, Daris M, Luu-The V, Tchernof A. Omental adipose tissue type 1 11 beta-hydroxysteroid dehydrogenase oxoreductase activity, body fat distribution, and metabolic alterations in women. J Clin Endocrinol Metab. 2009;94:3550-7.
30. Weinstein RS. Glucocorticoid-induced osteonecrosis. Endocrine. 2012;41:183-90.
31. Sheng HH, Zhang GG, Cheung WH, et al. Elevated adipogenesis of marrow mesenchymal stem cells during early steroid-associated osteonecrosis development. J Orthop Surg Res. 2007;2:15.
32. Motomura G, Yamamoto T, Irisa T, Miyanishi K, Nishida K, Iwamoto Y. Dose effects of corticosteroids on the development of osteonecrosis in rabbits. J Rheumatol. 2008;35:2395-9.